Tag: Takeda Pharmaceutical

December 12, 2019

Biotech Trends 2019: M&A Slows, CNS Therapies Make Headlines

2019 marked another critical year of growth for the biotech market. Learn about key biotech trends before the new year...
September 5, 2019

Investing in ADHD Treatments

The Investing News Network breaks down the key points you need to know about if you want to invest in...
November 20, 2018

Takeda and Shire Receive Major Acquisition Clearance

The European Union has given the acquisition conditional clearance. Conditions pertain to potential overlap between the companies' inflammatory bowel disease...
November 20, 2018

Shire: Phase I conditional clearance by the European Commission

Shire (NASDAQ:SHPG) announced the publication of a scheme document relating to the recommended cash and share offer being made by Takeda Pharmaceutical...
October 31, 2018

Takeda Reports Second Quarter FY2018 Results

Takeda Pharmaceutical (TOKYO:4502) Underlying Revenue +4.2% led by Growth Drivers, with growth in every region. As quoted in the press release:...
October 3, 2018

VIDEO — Life Science Update September 2018

With September officially behind us, the Investing News Network is taking a look back at some of the biggest news...
September 19, 2018

Molecular Templates Spikes on Big Pharma Deal

Molecular Templates announced on Wednesday that it will develop a protein-based oncology therapy with Takeda Pharmaceutical. Its share price rose...